278 related articles for article (PubMed ID: 32563984)
21. Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy.
Esim O; Ozkan CK; Sarper M; Savaser A; Ozkan Y
Curr Drug Deliv; 2020; 17(7):622-628. PubMed ID: 32394837
[TBL] [Abstract][Full Text] [Related]
22. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
[TBL] [Abstract][Full Text] [Related]
23. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
[TBL] [Abstract][Full Text] [Related]
24. Enhanced Antitumor Efficacy of Curcumin-Loaded PLGA Nanoparticles Coated with Unique Fungal Hydrophobin.
Sun L; Xu H; Xu JH; Wang SN; Wang JW; Zhang HF; Jia WR; Li LS
AAPS PharmSciTech; 2020 Jun; 21(5):171. PubMed ID: 32529560
[TBL] [Abstract][Full Text] [Related]
25. PLGA nanoparticle-based docetaxel/LY294002 drug delivery system enhances antitumor activities against gastric cancer.
Cai J; Qian K; Zuo X; Yue W; Bian Y; Yang J; Wei J; Zhao W; Qian H; Liu B
J Biomater Appl; 2019 May; 33(10):1394-1406. PubMed ID: 30952195
[TBL] [Abstract][Full Text] [Related]
26. Overcoming the diverse mechanisms of multidrug resistance in lung cancer cells by photodynamic therapy using pTHPP-loaded PLGA-lipid hybrid nanoparticles.
Pramual S; Lirdprapamongkol K; Jouan-Hureaux V; Barberi-Heyob M; Frochot C; Svasti J; Niamsiri N
Eur J Pharm Biopharm; 2020 Apr; 149():218-228. PubMed ID: 32112893
[TBL] [Abstract][Full Text] [Related]
27. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
[TBL] [Abstract][Full Text] [Related]
28. Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded Pluronic P105/d-α-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment.
Wu H; Zhong Q; Zhong R; Huang H; Xia Z; Ke Z; Zhang Z; Song J; Jia X
Int J Nanomedicine; 2016; 11():6337-6352. PubMed ID: 27932881
[TBL] [Abstract][Full Text] [Related]
29. PTX-loaded three-layer PLGA/CS/ALG nanoparticle based on layer-by-layer method for cancer therapy.
Wang F; Yuan J; Zhang Q; Yang S; Jiang S; Huang C
J Biomater Sci Polym Ed; 2018 Sep; 29(13):1566-1578. PubMed ID: 29749303
[TBL] [Abstract][Full Text] [Related]
30. Combinations of proteasome inhibitors with obatoclax are effective for small cell lung cancer.
Yin YP; Shi WH; Deng K; Liu XL; Li H; Lv XT; Lui VWY; Ding C; Hong B; Lin WC
Acta Pharmacol Sin; 2021 Aug; 42(8):1298-1310. PubMed ID: 33139838
[TBL] [Abstract][Full Text] [Related]
31. Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.
Mundra V; Peng Y; Kumar V; Li W; Miller DD; Mahato RI
Drug Deliv Transl Res; 2015 Jun; 5(3):199-208. PubMed ID: 25924699
[TBL] [Abstract][Full Text] [Related]
32. Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy.
Wahane A; Malik S; Shih KC; Gaddam RR; Chen C; Liu Y; Nieh MP; Vikram A; Bahal R
ACS Appl Mater Interfaces; 2021 Sep; 13(38):45244-45258. PubMed ID: 34524806
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
Baksi R; Singh DP; Borse SP; Rana R; Sharma V; Nivsarkar M
Biomed Pharmacother; 2018 Oct; 106():1513-1526. PubMed ID: 30119227
[TBL] [Abstract][Full Text] [Related]
34. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A
Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, purification, and anticancer effect of magnetic Fe
Wang K; Hu H; Zhang Q; Zhang Y; Shi C
J Microencapsul; 2019 Jun; 36(4):356-370. PubMed ID: 31190597
[TBL] [Abstract][Full Text] [Related]
36. A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers.
Parashar P; Tripathi CB; Arya M; Kanoujia J; Singh M; Yadav A; Saraf SA
Drug Deliv Transl Res; 2019 Feb; 9(1):37-52. PubMed ID: 30178279
[TBL] [Abstract][Full Text] [Related]
37. Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation
Wang Y; Guo M; Lin D; Liang D; Zhao L; Zhao R; Wang Y
Drug Deliv; 2021 Dec; 28(1):1510-1523. PubMed ID: 34263685
[TBL] [Abstract][Full Text] [Related]
38.
Lin MX; Lin SH; Lin CC; Yang CC; Yuan SY
Anticancer Res; 2018 Jun; 38(6):3435-3445. PubMed ID: 29848694
[TBL] [Abstract][Full Text] [Related]
39. Development and in vitro characterization of polymeric nanoparticles containing recombinant adrenomedullin-2 intended for therapeutic angiogenesis.
Quadros HC; Santos LMF; Meira CS; Khouri MI; Mattei B; Soares MBP; de Castro-Borges W; Farias LP; Formiga FR
Int J Pharm; 2020 Feb; 576():118997. PubMed ID: 31893542
[TBL] [Abstract][Full Text] [Related]
40. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH
Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
